These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209 [TBL] [Abstract][Full Text] [Related]
23. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy. Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596 [TBL] [Abstract][Full Text] [Related]
25. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas. Li GM; Sun XJ; Shao P Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279 [TBL] [Abstract][Full Text] [Related]
26. Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study. Capalbo D; Mattace Raso G; Esposito A; Di Mase R; Barbieri F; Meli R; Bruzzese D; Salerno M Clin Endocrinol (Oxf); 2014 Jun; 80(6):856-62. PubMed ID: 24372071 [TBL] [Abstract][Full Text] [Related]
27. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy. Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260 [TBL] [Abstract][Full Text] [Related]
29. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535 [TBL] [Abstract][Full Text] [Related]
30. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262 [TBL] [Abstract][Full Text] [Related]
31. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency. Murray RD; Shalet SM Clin Endocrinol (Oxf); 2005 Feb; 62(2):182-8. PubMed ID: 15670194 [TBL] [Abstract][Full Text] [Related]
32. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy. O'Neal DN; Hew FL; Best JD; Alford F Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452 [TBL] [Abstract][Full Text] [Related]
33. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency. Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495 [TBL] [Abstract][Full Text] [Related]
34. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170 [TBL] [Abstract][Full Text] [Related]
35. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235 [TBL] [Abstract][Full Text] [Related]
36. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report. Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951 [TBL] [Abstract][Full Text] [Related]
37. [The adult patient with a congenital GH deficiency. Cholesterol-lowering effects of therapy with biosynthetic GH]. Sartorio A; Conti A; Monzani M; Morabito F Minerva Endocrinol; 1994 Mar; 19(1):13-8. PubMed ID: 8035766 [TBL] [Abstract][Full Text] [Related]
38. Total serum homocysteine, folate and vitamin B12 in a Greek school age population. Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175 [TBL] [Abstract][Full Text] [Related]
39. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Tanriverdi F; Eryol NK; Atmaca H; Unluhizarci K; Ozdogru I; Sarikaya I; Bayram F; Kelestimur F Clin Endocrinol (Oxf); 2005 Jun; 62(6):706-12. PubMed ID: 15943833 [TBL] [Abstract][Full Text] [Related]
40. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]